Customers will also share data from studies using the technologies including an effort to investigate protein biomarkers for ...
SEATTLE--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of the Parse GigaLabâ„¢ to scale single cell sequencing to billions ...
Neuroblastoma (NB), the most prevalent extracranial solid tumor in children, poses a significant therapeutic challenge due to ...
SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of the Parse GigaLab™ to scale single cell sequencing to ...
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of the Parse GigaLabâ„¢ to scale single cell ...
Neuroblastoma (NB), the most prevalent extracranial solid tumor in children, poses a significant therapeutic challenge due to its metastasis and high heterogeneity. A recent study leveraging ...
Besides highlighting its sequencers, the company also launched a program to help researchers who want to incorporate spatial transcriptomic into their research.
MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced a commercial partnership with Human Cell Atlas (HCA) ...